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Lung cancer in never smokers, which has been partially attributed to household solid fuel use
(i.e., coal), is etiologically and clinically different from lung cancer attributed to tobacco
smoking. To explore the spectrum of driver mutations among lung cancer tissues from never
smokers, specifically in a population where high lung cancer rates have been attributed to in-
door air pollution from domestic coal use, multiplexed assays were used to detect >40 point
mutations, insertions, and deletions (EGFR, KRAS, BRAF, HER2, NRAS, PIK3CA, MEK1, AKT1, and
PTEN ) among the lung tumors of confirmed never smoking females from Xuanwei, China [32
adenocarcinomas (ADCs), 7 squamous cell carcinomas (SCCs), 1 adenosquamous carcinoma
(ADSC)]. EGFR mutations were detected in 35% of tumors. 46% of these involved EGFR exon
18 G719X, while 14% were exon 21 L858R mutations. KRAS mutations, all of which werein College of Medicine, Department of Epidemiology and Population Health, Division of Epidemiology,
onx, NY 10461, USA. Tel.: þ1 718 430 2138; fax: þ1 718 430 8780.
stein.yu.edu (H.D. Hosgood).
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1756 H.D. Hosgood et al.G12C_34G>T, were observed in 15% of tumors. EGFR and KRAS mutations were mutually exclu-
sive, and no mutations were observed in the other tested genes. Most point mutations were
transversions and were also found in tumors from patients who used coal in their homes.
Our high mutation frequencies in EGFR exon 18 and KRAS and low mutation frequency in EGFR
exon 21 are strikingly divergent from those in other smoking and never smoking populations
from Asia. Given that our subjects live in a region where coal is typically burned indoors,
our findings provide new insights into the pathogenesis of lung cancer among never smoking
females exposed to indoor air pollution from coal.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Lung cancer has been the most common cancer in the world
for over two decades [1]. Globally, about 53% of lung cancer
cases in women and 15% of lung cancer cases in men are not
attributable to tobacco use [2]. Evidence suggest that lung
cancer in never smokers has unique risk factors, clinical
features, and histological distributions when compared to
lung cancer cases attributed to smoking tobacco, with lung
cancer in never smokers presenting predominately as
adenocarcinoma and in females [3,4].
Given that most women throughout Asia historically do
not smoke, they constitute an ideal study population
which can enable the elucidation of risk factors for
developing never smoking lung cancer. Interestingly, never
smoking women in certain regions of Asia experience some
of the highest lung cancer rates in the world [5,6]. These
rates have been partially attributed to known environ-
mental risk factors such as fuel combustion byproducts
from indoor heating and cooking and environmental to-
bacco smoke [5,7]. Xuanwei, China is a unique region in
which to study these environmental exposures as it has the
highest female prevalence of lung cancer in China and a
majority of women are never smokers [6,8,9]. Nearly all
Xuanwei women have substantial exposure to indoor air
pollution from domestic fuel combustion for heating and
cooking [10,11], an established risk factor for lung
cancer [12].
Driver mutations occur in genes that encode signaling
proteins that play key roles in the regulation of cell death
and proliferation [13]. Many driver mutations have been
found in lung cancer and are now used to classify tumors at
the molecular level. Given the dramatic and prolonged
benefit in patients with EGFR mutant tumors treated with
EGFR tyrosine kinase inhibitors [14], most reports have
focused on EGFR mutations; however, few studies have
characterized tumors specifically from never smokers
[15,16], and even fewer studies have evaluated the impact
of environmental exposures on these mutation patterns. To
date, most reports have evaluated mutations in relation to
environmental tobacco smoke and radon exposures
[17e19]. For this reason, this study sought to evaluate
EGFR, KRAS, BRAF, HER2, NRAS, PIK3CA, MEK1, AKT1, and
PTEN driver mutations present in tumor samples collected
in Xuanwei to produce new insights into the pathogenesis of
lung cancer among never smoking females exposed to in-
door air pollution from coal.Methods
Lung cancer patients presenting to hospitals in Xuanwei,
China were eligible for participation in our ongoing study.
During surgery, a piece of tumor from the lung was
extracted, formalin-fixed, and paraffin embedded. This
study was reviewed and approved by the National Institutes
of Health’s Office of Human Subjects Research.
In total, 40 formalin-fixed paraffin embedded (FFPE)
tissues were collected from never smoking female lung
cancer cases in Xuanwei. Expert consensus review (by KDJ
and JS) of the FFPE tissue samples from this series of 40
never smoking female lung cancer cases was conducted to
determine histology and to identify viable tumor areas for
dissection and subsequent nucleic acid isolation. The
selected tumor areas for use in DNA isolation were
required to contain at least 50% viable tumor cells. Of the
40 cases, 32 (80.0%) of these never smoking female cases
were adenocarcinomas, seven (17.5%) were squamous cell
carcinomas, and one (2.5%) was an adenosquamous
carcinoma.
Two multiplexed assays were used to evaluate the FFPE
tissue DNA for more than 40 recurrent mutations in 9 genes
relevant to existing and emerging targeted lung cancer
therapies. First, the amplification of DNA through Applied
Biosystem’s SNaPshot was used to detect 38 different
recurrent point mutations in 8 driver genes (EGFR, KRAS,
BRAF, NRAS, PIK3CA, MEK1, AKT1, and PTEN ). This plat-
form involved multiplexed amplification of DNA targets by
the polymerase chain reaction (PCR) with unlabeled oligo-
nucleotide primers, multiplexed single-base primer exten-
sion with fluorescently-labeled dideoxynucleotides, and
analysis of labeled primer-extension products by capillary
electrophoresis. The second assay was a separate PCR-
based sizing technique that simultaneously assesses tu-
mors for recurrent insertions in EGFR and HER2 and de-
letions in EGFR that would not be comprehensively
detected by the SNaPshot technique. This assay was used
for EGFR exon 19 deletions, EGFR exon 20 insertions, and
HER2 exon 20 insertions. Compared to direct sequencing,
these assays offer higher analytical sensitivity and reduced
complexity. They also provide a robust and accessible
approach for the rapid identification of important muta-
tions in lung cancer [20].
Chi-squared and Fischer’s exact tests were used to
compare the number of specific mutations between sub-
groups. Two-sided p-values are reported.
Table 1 Tumor and patient characteristics of never smoking female lung cancers from Xuanwei, China.
Adenocarcinoma Squamous cell carcinoma Adenosquamous All lung cancer cases
n Z 32 n Z 7 n Z 1 n Z 40
n % n % n % n %
Age (mean ± std) 46.6  10.1 45.7  10.6 48.0  not applicable 46.5  10.0
Differentiation
Well differentiated 6 18.8 1 14.3 0 0.0 7 17.5
Moderately differentiated 21 65.6 4 57.1 0 0.0 25 62.5
Poorly differentiated 4 12.5 2 28.6 1 100.0 7 17.5
Missing 1 3.1 0 0.0 0 0.0 1 2.5
Fuel used for heating and cooking
Coal only 29 90.6 4 57.1 0 0.0 33 82.5
Coal and wood 1 3.1 0 0.0 0 0.0 1 2.5
Electricity 0 0.0 2 28.6 0 0.0 2 5.0
Missing 2 6.3 1 14.3 1 100.0 4 10.0
Never smoking lung cancer mutations 1757Results
The 40 FFPE tissues collected among female never smok-
ing lung cancer cases in Xuanwei were predominantly
adenocarcinomas (80.0%) and to a lesser exent squamous
cell carcinomas (17.5%). The mean (standard deviation)
age of these cases was 46.5 years old (10.0 years)
(Table 1).
Mutations in tumor tissues were observed only in EGFR
and KRAS. No mutations were detected for BRAF, NRAS,
PIK3CA, MEK1, HER2, AKT1, or PTEN. KRAS mutations were
found in 15% of all tissues, and EGFR mutations were found
in 35% of all tissues (Fig. 1). When stratifying the EGFR
mutations by type, point mutations were found in 22% of all
tissues, deletions in 10%, and insertions in 3% (Fig. 1). All
EGFR and KRAS mutations were mutually exclusive. While
the distribution of EGFR mutations suggests the potential
for variability by age, the distributions were fairly similar
by histology and differentiation (Table 2).
Among the 15 EGFR mutations, ten were point muta-
tions, four were exon 19 deletions, and one was an exon 20
insertion (Table 3). Eight point mutations were in adeno-
carcinomas, with one tissue having two different EGFR
point mutations, and one mutation was in a squamous cell
carcinoma. EGFR point mutations were predominately G719
mutations (nZ 7, or 46% of all EGFR mutations) on exon 18
(Fig. 2). EGFR point mutations were also observed on exon
21 (L858R, n Z 2, or 13% of all EGFR mutations). Three
adenocarcinomas and one squamous cell carcinoma
harbored exon 19 deletions, and one adenocarcinoma
contained an exon 20 insertion. Among the six KRAS mu-
tations, all were KRAS G12C_34G>T point mutations (Table
3). Five of these mutations were found in adenocarcinomas
and 1 was in a squamous cell carcinoma.
EGFR and KRAS mutations were observed in both ade-
nocarcinomas and squamous cell carcinomas and for a
range of differentiations and ages (Table 3). One consis-
tency observed for all point mutations was the use of only
coal for the case’s household cooking and heating needs,
which may not be surprising given that most patients were
coal-only users. This consistency was not observed for EGFR
deletions. No significant differences were observed whencomparing mutation distributions by coal type: bituminous
coal (n Z 21) versus anthracite coal (n Z 12) (p > 0.05).Discussion
We have conducted, to the best of our knowledge, the first
analysis of point mutations, insertions, and deletions in a
spectra of known lung cancer driver genes that includes
genes beyond EGFR and KRAS, in tumor tissues from a
population of never smokers who used solid fuel in their
home for heating and cooking. When compared to previ-
ously studied populations, our results suggest a unique
distribution of EGFR and KRAS mutations. Specifically, our
observed point mutation frequencies of EGFR exons 18 and
21, suggest a unique mutational pattern in lung cancer tu-
mors for subjects with substantial indoor air pollution
exposure from coal burning.
Our assay evaluated the following EGFR point mutations:
G719: p.G719C c.2155G_T, p.G719S c.2155G_A, p.G719A
c.2156G_C; T790M: p.T790M c.2369C_T; L858: p.L858R
c.2573T_G; L861: p.L861Q c.2582T_A. Similar to other
studies in never smokers [18,19,21], we found a lack of
association between clinicopathological characteristics and
EGFR mutations. In terms of overall EGFR mutation fre-
quencies, our results are also consistent with previous re-
ports that about 30% of lung cancer tumors from Eastern
Asia harbor EGFR mutations, and about 40% of lung cancer
tumors from females harbor EGFR mutations [22]. When
summarizing all lung cancer histologies, across multiple
ethnicities including both those that do and do not smoke
tobacco, EGFR mutations are mostly exon 19 deletions
(44%) and exon 21 L858R point mutations (41%), with only
limited exon 20 insertions (5%) and exon 18 G719 point
mutations (4%) [22]. Our observations are fairly consistent
with the findings from characterizations of tissues from
never smoking females both in East Asia and in North
America, with respect to the percentage of EGFR mutations
that are exon 19 deletions [15,18,19,21,23] and exon 20
insertions [21].
In contrast, a striking difference exists between our
findings and those typically found for the incidence of G719
Figure 1 EGFR point mutations, insertions, and deletions, and KRAS point mutations detected in never smoking female (a)
adenocarcinomas, (b) squamous cell carcinomas, and (c) all lung cancersy.
1758 H.D. Hosgood et al.mutations in exon 18 (50% versus 4%) and L858 mutations in
exon 21 (14% versus 41%). Interestingly, a recent charac-
terization of lung adenocarcinomas from never smoking
females in Shanghai [15] found virtually identical mutation
rates for exon 18 (3%) and exon 21 mutations (42%) as those
typically found across ethnicities when including both those
that do and do not smoke tobacco [22]. When taken
together, these results suggest that not only is our high
incidence of G719 mutations in exon 18 and unusually low
incidence of L858 mutations in exon 21 different from the
general population of all lung cancer tumors, it is also
divergent from tumors collected from other never smoking
female populations in China. Indeed, the distribution of
mutations we observed among all lung cancers was signifi-
cantly different than those previously observed in the
general population [22] (p < 0.0001) and in a series of never
smoking females from Asia [21] (p < 0.0001) (Fig. 2). Therewas no statistical difference between the mutation distri-
butions of these two comparative, previously reported
populations (p > 0.05). Of note, PCR carryover of the EGFR
exon 18 mutation is unlikely to explain our results, as no
template controls are used throughout our assay [20].
Recently, the TCGA study of 178 squamous cell lung cancer
samples found no EGFR L858R or exon 19 deletions [24],
further highlighting the uniqueness of our study population
and findings.
The high percentage of samples with KRAS mutations
(15%) in our series is also of interest primarily because KRAS
mutations are reportedly more rare in other populations
from Asia (w5%) [25,26] and populations of never smokers
from Asia (w2%) [15,18]. Our findings are consistent with a
previous analysis of nonsmoking women in this region of the
world, which found that 22% of the lung tumors or sputum
samples from Xuanwei harbored a KRAS mutation compared
Table 2 Associations between clinicopathologic characteristics and EGFR and KRAS events among never smoking female lung
cancer patients.a
Wildtype EGFR point mutations, deletions, and insertions KRAS point mutations
n % Absent Present p-Valueb p-Valuec Absent Present p-Valueb p-Valuec
n % n % n % n %
Age 0.22 0.21 1.00 0.73
<50 years old 11 57.9 14 56.0 5 35.7 16 48.5 3 50.0
50 years old 8 42.1 11 44.0 9 64.3 17 51.5 3 50.0
Histology 0.66 0.62 0.0 1.00 0.81
Adenocarcinoma 15 78.9 20 80.0 12 85.7 27 81.8 5 83.3
Squamous cell
carcinoma
4 21.1 5 20.0 2 14.3 6 18.2 1 16.7
Differentiation 0.92 0.98 0.44 0.43
Well differentiated 4 21.1 4 16.0 3 21.4 7 21.2 0 0.0
Moderately
differentiated
11 57.9 16 64.0 9 64.3 20 60.6 5 83.3
Poorly differentiated 3 15.8 4 16.0 2 14.3 5 15.2 1 16.7
a Restricted to adenocarcinomas and squamous cell carcinomas; Wildtype subjects are defined as having no EGFR point mutations,
deletions, or insertions, and no KRAS point mutations; p-values determined by Chi-squared and Fischer’s exact tests.
b p-Value for EGFR point mutations, deletions, and insertions being present versus absent, or KRAS point mutations being present
versus absent, respectively.
c p-Value for EGFR point mutations, deletions, and insertions being present versus wildtype, or KRAS point mutations being present
versus wildtype, respectively.
Never smoking lung cancer mutations 1759to 7% of samples from urban Beijing [27]. An additional
study carried out in Xuanwei tumors found the frequency of
KRAS mutations to be slightly higher (29%) [28]. Both of the
previous studies [27,28], as well as the current report,
found a majority (>66%) of the KRASmutations to be G to T.Table 3 EGFR and KRAS point mutations, deletions, and insert
Gene Event Description Histology
EGFR Point mutation EGFR_G719A_2156G>Ca Adenocarcino
EGFR_L858R_2573T>G Adenocarcino
EGFR_G719C_2155G>T Adenocarcino
EGFR_G719A_2156G>C Adenocarcino
EGFR_G719C_2155G>T Adenocarcino
EGFR_L858R_2573T>G Adenocarcino
EGFR_G719S _2155G>T Adenocarcino
EGFR_G719S_2155G>A Adenocarcino
EGFR_G719C_2155G>T Squamous Ce
Deletion EGFR_19-15bpDel Adenocarcino
EGFR_19-15bpDel Adenocarcino
EGFR_19-15bpDel Adenocarcino
EGFR_19-15bpDel Squamous ce
Insertion E20-6bp-ins. Adenocarcino
KRAS Point mutation KRAS(R)G12C_34G>T Adenocarcino
KRAS(R)G12C_34G>T Adenocarcino
KRAS(R)G12C_34G>T Adenocarcino
KRAS(R)G12C_34G>T Adenocarcino
KRAS(R)G12C_34G>T Adenocarcino
KRAS(R)G12C_34G>T Squamous Ce
a This tumor also had a second EGFR point mutation [EGFR(R)L861Q
b Type of fuel currently used at the time of surgery.Given that our population was from the a rural region of
the Yunnan Province, whereas the populations used for
previous characterizations of never smoking female lung
tumors were selected from urban Shanghai and Beijing, our
divergent findings for KRAS mutations and EGFR mutationsions in never smoking lung cancer tumors.
Differentiation Age Fuel used for heating
and cookingb
ma Well 40 Only coal
ma Well 40 Only coal
ma Well 56 Only coal
ma Moderately 52 Only coal
ma Moderately 52 Only coal
ma Moderately 58 Only coal
ma Poorly 30 Only coal
ma Poorly 40 Only coal
ll Carcinoma Moderately 58 Only coal
ma Moderately 43 Only coal
ma Moderately 52 Unknown
ma Moderately 58 Coal and wood
ll carcinoma Moderately 50 Electric
ma Moderately 50 Only coal
ma Moderately 30 Only coal
ma Moderately 40 Only coal
ma Moderately 50 Only coal
ma Moderately 52 Only coal
ma Moderately 52 Only coal
ll Carcinoma Poorly 24 Only coal
_2582T>A].
Figure 2 Distribution of EGFR exon 18 point mutations, exon 19 deletions, exon 20 insertions, and exon 21 point mutations in
never smoking female adenocarcinomas (nZ 32), squamous cell carcinomas (nZ 7), and all lung cancers (nZ 40) from Xuanwei,
Chinay.
1760 H.D. Hosgood et al.on exons 18 and 21 may be due to the varying environ-
mental exposures in urban versus rural China. The main
difference in environmental exposures is likely indoor air
pollution associated with in-home solid fuel use. The pri-
mary source of indoor air pollution in Xuanwei is smoke
from domestic fuel combustion for heating and cooking,
with most residents burning bituminous coal and some
anthracite coal and wood. Xuanwei residents, and more
specifically the women who primarily do all of the cooking,
experience substantial exposures to indoor air pollution
attributed to coal burning [29]. In Shanghai and Beijing,
most residents typically use modern fuel sources, such as
natural gas or electricity, for their heating and cooking
needs.
Coal combustion for heating and cooking increases the
levels in the home of known carcinogens, such as polycyclic
aromatic hydrocarbons (PAHs) [30]. Although more research
is needed to determine which coal constituent(s) is driving
the risk of lung cancer associated with household coal use,
it is conceivable that there may be mutation patterns in
lung cancer tumors that will vary based on not only smoking
status, but also these environmental exposures experi-
enced by the patient. In support of our hypothesis, PAHs
have been shown to increase intracellular calcium in human
cell lines [31], which may lead to EGFR-dependant cell
proliferation [32,33]. PAH-DNA adducts have also been
observed in bronchoalveolar lavage in Xuanwei residents
burning coal [34], suggesting that the lung tumors in our
never smoking tissues are being induced by coal combustion
byproducts, such as PAHs, potentially leading to unique
mutational patterns. Further, mutations in the p53 gene in
tumor samples from nonsmoking women in Xuanwei were
consistent with those of PAHs and different from those of
lung cancer tumors from smokers [28]. This previous studyin Xuanwei found that 76% of the mutations in TP53 were
G > T and that 33% of all the mutations clustered at a GC-
rich region, which is a preferred binding site for PAHs.
Additional evidence for the role of PAHs in the mutation
spectrum was demonstrated by the fact that smoky coal
condensate induced primarily G > T mutations at a fre-
quency (78e86%) that was similar to that of B[a]P (77%) in
Salmonella [35]. Since most of the mutations observed in
our study were G to T transversions and some G to C
transversions, which are rarely observed in other pop-
ulations, our findings suggest that coal-derived carcinogens
(i.e., PAHs) are the etiologic agent in this population.
In conclusion, the tissues from our never smoking female
population harbored a strikingly divergent mutational
pattern for EGFR and KRAS, specifically with respect to
EGFR exon 18, EGFR exon 21, compared to other never
smoking female populations in Asia. Our findings have hel-
ped evaluate the impact coal combustion byproducts have
on the lung, and provide new insights into the pathogenesis
of lung cancer among never smoking females exposed to
indoor air pollution from coal. We found that mutations in
KRAS and EGFR were mutually exclusive, potentially sug-
gesting differing carcinogenic pathways; however, addi-
tional research is needed to determine if these mutations
are indeed driver mutations or merely passenger mutations
[36]. Due to our small sample size, caution should be used
when drawing conclusions from our results, particularly
from subset analyses, until these findings are replicated in a
larger study. Our results can serve as a comparative model
for the study of lung cancer tumors from never smoking
females without this exposure, both in Asia and elsewhere,
and also highlight the potential importance of integrating
environmental exposure histories into clinical and trans-
lational research. In this vein, however, our results may
Never smoking lung cancer mutations 1761only be relevant to similar populations, with similar his-
tologies and grades of lung cancer. Efforts should be made
to evaluate the driver mutation spectra of subjects who use
additional household fuel sources beyond only coal, which
was the case for most of our subjects. Future research is
needed to integrate additional exposure data exploring
coal use doseeresponse analyses in terms of duration, in-
tensity, and amount of coal use and exposure to environ-
mental tobacco smoke.Conflicts of interest
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